Abstract 3308: Urine epigenetic biomarkers for NSCLC diagnosis
Lane Lerner(University of Illinois Chicago), Alicia Hulbert(Johns Hopkins University), Robert A. Winn(Virginia Commonwealth University), James G. Herman(UPMC Hillman Cancer Center), Αναστασία Κοττόρου(Johns Hopkins University), Lily Zheng(Johns Hopkins University), Tomoaki Ito(Juntendo University Shizuoka Hospital), Chen Chen(Central South University), Enrico Benedetti(University of Illinois Chicago), Malcolm V. Brock(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Tza-Huei Wang(University of Baltimore), Beverly Lee(Lovelace Respiratory Research Institute)
Cited by 0
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|909